REBOA has traditionally been used reactively and often as a last resort, due to extremely limited 30-minute safe occlusion times. This week’s announcement highlights the evolving new capabilities now available to surgeons with the world’s first and only purpose-built partial balloon occlusion technology.

The patented pREBOA-PRO™ Catheter is designed with flow channels which enable precise, smooth manual control of patient blood flow. PRO’s ability to precisely control arterial flow enables surgeons to immediately stabilize blood pressure and reduce blood loss while simultaneously diminishing the risk of distal ischemia and detrimental reperfusion sequelae associated with old REBOA.

“This new capability was designed with the surgeon in mind and helps eliminate a major barrier to broader utility. With this new pREBOA-PRO™ catheter, our surgical teams can safely intervene earlier and gain a new level of control, especially during the initial chaos seen in challenging trauma cases. Gaining control early reduces the collective temperature in the room and provides critical extended time to get to definitive intervention,” said Dr. Chance Spalding, a Trauma and Critical Care Surgeon at Mount Carmel East Hospital in Columbus, Ohio and Prytime’s Chief Medical Officer.